459 related articles for article (PubMed ID: 11902539)
1. Esthesioneuroblastoma: a meta-analysis and review.
Dulguerov P; Allal AS; Calcaterra TC
Lancet Oncol; 2001 Nov; 2(11):683-90. PubMed ID: 11902539
[TBL] [Abstract][Full Text] [Related]
2. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
[TBL] [Abstract][Full Text] [Related]
3. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
4. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.
Malouf GG; Casiraghi O; Deutsch E; Guigay J; Temam S; Bourhis J
Eur J Cancer; 2013 Apr; 49(6):1324-34. PubMed ID: 23312882
[TBL] [Abstract][Full Text] [Related]
5. Esthesioneuroblastoma: updating histologic grading as it relates to prognosis.
Gallagher KK; Spector ME; Pepper JP; McKean EL; Marentette LJ; McHugh JB
Ann Otol Rhinol Laryngol; 2014 May; 123(5):353-8. PubMed ID: 24668054
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
[TBL] [Abstract][Full Text] [Related]
7. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
[TBL] [Abstract][Full Text] [Related]
8. Salvage treatment of late neck metastasis in esthesioneuroblastoma: a meta-analysis.
Gore MR; Zanation AM
Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1030-4. PubMed ID: 19841344
[TBL] [Abstract][Full Text] [Related]
9. Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review.
El Kababri M; Habrand JL; Valteau-Couanet D; Gaspar N; Dufour C; Oberlin O
J Pediatr Hematol Oncol; 2014 Mar; 36(2):91-5. PubMed ID: 24390450
[TBL] [Abstract][Full Text] [Related]
10. Combined modality therapy of esthesioneuroblastoma.
McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
[TBL] [Abstract][Full Text] [Related]
11. Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis.
Vuong HG; Ngo TNM; Dunn IF
J Neurooncol; 2021 May; 153(1):15-22. PubMed ID: 33770323
[TBL] [Abstract][Full Text] [Related]
12. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
[TBL] [Abstract][Full Text] [Related]
13. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?
Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK
Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569
[TBL] [Abstract][Full Text] [Related]
14. Patterns of failure and outcome in esthesioneuroblastoma.
Dias FL; Sa GM; Lima RA; Kligerman J; Leoncio MP; Freitas EQ; Soares JR; Arcuri RA
Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1186-92. PubMed ID: 14623748
[TBL] [Abstract][Full Text] [Related]
15. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
[TBL] [Abstract][Full Text] [Related]
16. Esthesioneuroblastoma: is there a need for elective neck treatment?
Demiroz C; Gutfeld O; Aboziada M; Brown D; Marentette LJ; Eisbruch A
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e255-61. PubMed ID: 21676553
[TBL] [Abstract][Full Text] [Related]
17. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
[TBL] [Abstract][Full Text] [Related]
18. Management of orbital invasion in esthesioneuroblastoma: 14 years' experience.
Li R; Tian S; Zhu Y; Yan L; Zhu W; Quan H; Wang S
Radiat Oncol; 2019 Jun; 14(1):107. PubMed ID: 31196122
[TBL] [Abstract][Full Text] [Related]
19. Clincopathological analysis of olfactory neuroblastoma.
Fukushima S; Sugita Y; Niino D; Mihashi H; Ohshima K
Brain Tumor Pathol; 2012 Oct; 29(4):207-15. PubMed ID: 22331316
[TBL] [Abstract][Full Text] [Related]
20. Long-term analysis of multimodality treatment outcomes and prognosis of esthesioneuroblastomas: a single center results of 138 patients.
Sun M; Wang K; Qu Y; Zhang J; Zhang S; Chen X; Wang J; Wu R; Zhang Y; Yi J; Xiao J; Xu G; Huang X; Luo J
Radiat Oncol; 2020 Sep; 15(1):219. PubMed ID: 32948223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]